-
Posting Date: 01/02/2025
Magnetic Resonance Angiography (MRA)
Magnetic Resonance Angiography (MRA) gadolinium, contrast, imaging L33633 https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33633 A56747 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=56747 70544, [...]
Read More -
Posting Date: 01/02/2025
Who is My LSO?
Who is My LSO? Select the Manage Account button on the NGSConnex home page. Select User Profile and scroll down to the ‘System Access’ section. Select the Checkbox next to the provider record you want to determine the LSO for. [...]
Read More -
Posting Date: 07/18/2023
Medical Review: Targeted Probe and Educate Review Topics
Jurisdiction 6 Part A Targeted Probe and Educate: Medical Review Topics Topic CPT Code(s) Common Denials Resources Nail Debridement 11719-11721 55B23– The service provided is not covered Medicare benefit. [...]
Read More -
Posting Date: 01/02/2025
LCD/Billing and Coding Article Updates – December 2024–January 2025
LCD/Billing and Coding Article Updates – December 2024–January 2025 Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG) (L39189) – Effective 12/15/2024 Under the Indications of Coverage, added the following language: "The use of [...]
Read More -
Posting Date: 07/15/2022
LSO Responsibilities
LSO Responsibilities The LSO is responsible for managing and monitoring access for other NGSConnex users within the organization. LSOs are responsible for approving access to users requesting data access to a specific provider account [...]
Read More -
Posting Date: 01/03/2025
All LOBs - Customer Xperience
Thank You For Your Feedback! /web/ngs/news-article-details?selectedArticleId=11220579
Read More -
Posting Date: 01/03/2025
12/12/2024 Part B POE Advisory Group Meeting
12/12/2024 Part B POE Advisory Group Meeting Meeting Minutes Meeting Time: 10:00 a.m.‒12:00 p.m. ET Member Attendees: Elizabeth Aldrich, Dawson Ballard, Doris Barnes, Sheila Bembeneck, Madelon Berger, Louise Bertrand, Kimberly Bischel, [...]
Read More -
Posting Date: 01/03/2025
Billing and Coding: Bevacizumab and Biosimilars
Billing and Coding: Bevacizumab and Biosimilars drug, retinal A52370 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52370 C9257, J3590, J9035, Q5107, Q5118, Q5126, Q5129, 67028
Read More